Showing results (941-950 of 1,620) with videos related to

Sort By:
Pageof 162
Plos One|September 8, 2018
Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometrySrikanth Karnati, Vannuruswamy Garikapati, Gerhard Liebisch, et al.
Digestive Diseases and Sciences|September 9, 2011
Probe-based confocal laser microscopy identifies criteria predictive of active celiac sprueHeiko Pohl, Barbara T Tanczos, Birgit Rudolph, et al.
Virchows Archiv : an International Journal of Pathology|January 26, 2019
AL amyloidosis with a localized B cell neoplasiaChristiane Stuhlmann-Laeisz, Stefan O Schönland, Ute Hegenbart, et al.
The Journal of Biological Chemistry|February 2, 2019
Dopamine transporter forms stable dimers in the live cell plasma membrane in a phosphatidylinositol 4,5-bisphosphate-independent mannerAnand Kant Das, Oliver Kudlacek, Florian Baumgart, et al.
Scientific Reports|March 8, 2020
Verifying molecular clusters by 2-color localization microscopy and significance testingAndreas M Arnold, Magdalena C Schneider, Christoph Hüsson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2006
Underlying aortic pathology and clinical health status determine success of endovascular stent-grafting for descending thoracic aortic diseaseDietrich Baumgart, Holger Eggebrecht, Ulf Herold, et al.
Pediatric Pulmonology|March 1, 1994
Continued pulmonary recovery observed after discontinuing extracorporeal membrane oxygenationM J Antunes, J A Cullen, W J Holt, et al.
British Journal of Pharmacology|October 10, 2013
Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitorT K Albert, C Rigault, J Eickhoff, et al.
Alimentary Pharmacology & Therapeutics|May 31, 2016
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 studyC Schmidt, T Ahmad, Z Tulassay, et al.
International Journal of Cancer|March 5, 2019
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer modelsTatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, et al.
Pageof 162